Goldman Sachs’s Allied Healthcare Products AHPI Stock Holding History

Goldman Sachs’s Portfolio AHPI Stock Details AHPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,228	Closed	-$26K	–	7048
2017 Q1	$26K	Sell	13,228 -3,467	-21%	-$7.11K	﹤0.01%	6456
2016 Q4	$33K	Sell	16,695 -5,195	-24%	-$11.6K	﹤0.01%	6507
2016 Q3	$36K	Buy	21,890 +1,731	+9%	+$2.1K	﹤0.01%	6586
2016 Q2	$24K	Sell	20,159 -1,607	-7%	-$2.04K	﹤0.01%	6665
2016 Q1	$30K	Buy	21,766 +10,184	+88%	+$16.2K	﹤0.01%	6619
2015 Q4	$26K	Sell	11,582 -250	-2%	-$600	﹤0.01%	6782
2015 Q3	$27K	Buy	11,832 +783	+7%	+$2.29K	﹤0.01%	6964
2015 Q2	$35K	Sell	11,049 -119	-1%	-$363	﹤0.01%	6967
2015 Q1	$36K	Sell	11,168 -136	-1%	-$437	﹤0.01%	6787
2014 Q4	$42K	Buy	11,304 +319	+3%	+$1.15K	﹤0.01%	6859
2014 Q3	$44K	Buy	+10,985	New	+$47.2K	﹤0.01%	6858

Other funds holding AHPI

Oppenheimer & Close New York $159M AUM 60.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VWA

V Wealth Advisors Overland Park, Kansas $125M AUM 24.7% 1-Year Est. Return

Goldman Sachs's AHPI Position: Q2 2017 in Review

Goldman Sachs sold out of Allied Healthcare Products (AHPI) in Q2 2017, closing a stake of 13,228 shares — an estimated $26K sold.

Goldman Sachs first reported a position in AHPI in Q3 2014 and held it in 11 quarters. The position peaked at $44K in Q3 2014. 10 funds tracked by Wall St. Rank hold AHPI as of Q2 2017.

Goldman Sachs reported no remaining Allied Healthcare Products position as of Q2 2017 after selling out during the quarter.
Goldman Sachs sold 13,228 Allied Healthcare Products shares in Q2 2017, an estimated $26K.
Goldman Sachs first reported a position in Allied Healthcare Products in Q3 2014 and held it in 11 quarters.
Goldman Sachs's Allied Healthcare Products position peaked at $44K in Q3 2014.
10 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.